Northwest Investment Counselors’s GSK GSK Stock Holding History

Northwest Investment Counselors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$23.3K	Buy	+570	New	+$23.3K	0.01%	331
2024 Q2	–	Sell	-400	Closed	-$17.1K	–	291
2024 Q1	$17.1K	Buy	+400	New	+$16.5K	﹤0.01%	331
2023 Q4	–	Sell	-420	Closed	-$15.2K	–	292
2023 Q3	$15.2K	Buy	420 +20	+5%	+$710	﹤0.01%	341
2023 Q2	$14.3K	Sell	400 -377	-49%	-$13.5K	﹤0.01%	349
2023 Q1	$27.6K	Hold	777	–	–	0.01%	296
2022 Q4	$27.3K	Buy	777 +600	+339%	+$20K	0.01%	301
2022 Q3	$5K	Sell	177 -1	-0.6%	-$38	﹤0.01%	427
2022 Q2	$10K	Buy	+178	New	+$9.83K	﹤0.01%	356
2020 Q4	–	Sell	-433	Closed	-$20K	–	260
2020 Q3	$20K	Buy	+433	New	+$21.7K	0.01%	266
2019 Q4	–	Sell	-433	Closed	-$23K	–	294
2019 Q3	$23K	Buy	+433	New	+$22.3K	0.01%	277
2017 Q4	–	Sell	-909	Closed	-$46K	–	204
2017 Q3	$46K	Buy	+909	New	+$46.1K	0.02%	185

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northwest Investment Counselors's GSK Position: Q3 2024 in Review

Northwest Investment Counselors opened a new position in GSK (GSK) in Q3 2024: 570 shares worth $23.3K. The stake represents 0.01% of the portfolio and ranks #331 among its holdings. This is a return to the name: Northwest Investment Counselors previously reported a position in GSK as recently as Q1 2024.

Northwest Investment Counselors first reported a position in GSK in Q3 2017 and has held it in 11 quarters since. The position peaked at $46K in Q3 2017. 900 funds tracked by Wall St. Rank hold GSK as of Q3 2024.

Northwest Investment Counselors held 570 shares of GSK worth $23.3K as of Q3 2024.
GSK was a new Northwest Investment Counselors position in Q3 2024.
GSK made up 0.01% of Northwest Investment Counselors's portfolio in Q3 2024, its #331 holding.
Northwest Investment Counselors first reported a position in GSK in Q3 2017 and has held it in 11 quarters since.
Northwest Investment Counselors's GSK position peaked at $46K in Q3 2017.
900 funds tracked by Wall St. Rank held GSK as of Q3 2024.

Based on Northwest Investment Counselors's 13F filing for Q3 2024, filed 21 Oct 2024.